Pulmonx Corp
(LUNG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,037 | 0 | 0 | N/A | 0 |
| Receivables | 5,260 | 0 | 0 | N/A | 0 |
| Inventories | 9,288 | 0 | 0 | N/A | 0 |
| TOTAL | $55,622 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,164 | N/A | N/A | N/A | N/A |
| Intangibles | 2,764 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,694 | 0 | 0 | 0 | 0 |
| TOTAL | $15,622 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $71,244 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,297 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 8,844 | 0 | 0 | N/A | 0 |
| Other current liabilities | 1,856 | 0 | 0 | N/A | 0 |
| TOTAL | $15,174 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,763 | 0 | 0 | N/A | 0 |
| Deferred Revenues | 92 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 246,142 | 0 | 0 | 0 | 0 |
| TOTAL | $262,959 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $278,133 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,669 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | 0 | 0 | N/A | 0 |
| Retained earnings | -233,437 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 1,648 | 0 | 0 | 0 | 0 |
| TOTAL | $-206,889 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $71,244 | $0 | $0 | $0 | $0 |